JP2004526725A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526725A5
JP2004526725A5 JP2002571445A JP2002571445A JP2004526725A5 JP 2004526725 A5 JP2004526725 A5 JP 2004526725A5 JP 2002571445 A JP2002571445 A JP 2002571445A JP 2002571445 A JP2002571445 A JP 2002571445A JP 2004526725 A5 JP2004526725 A5 JP 2004526725A5
Authority
JP
Japan
Prior art keywords
optionally substituted
represented
alkyl
methyl
structural formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002571445A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526725A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/007718 external-priority patent/WO2002072528A1/en
Publication of JP2004526725A publication Critical patent/JP2004526725A/ja
Publication of JP2004526725A5 publication Critical patent/JP2004526725A5/ja
Pending legal-status Critical Current

Links

JP2002571445A 2001-03-14 2002-03-12 フッ化トリエンおよびrxrモジュレータとしてのその使用 Pending JP2004526725A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27580801P 2001-03-14 2001-03-14
PCT/US2002/007718 WO2002072528A1 (en) 2001-03-14 2002-03-12 Fluorinated trienes and their use as rxr modulators

Publications (2)

Publication Number Publication Date
JP2004526725A JP2004526725A (ja) 2004-09-02
JP2004526725A5 true JP2004526725A5 (cg-RX-API-DMAC10.html) 2005-12-22

Family

ID=23053886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002571445A Pending JP2004526725A (ja) 2001-03-14 2002-03-12 フッ化トリエンおよびrxrモジュレータとしてのその使用

Country Status (7)

Country Link
US (1) US20040248919A1 (cg-RX-API-DMAC10.html)
EP (1) EP1368296A1 (cg-RX-API-DMAC10.html)
JP (1) JP2004526725A (cg-RX-API-DMAC10.html)
AU (1) AU2002255732B2 (cg-RX-API-DMAC10.html)
CA (1) CA2438874A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA03008229A (cg-RX-API-DMAC10.html)
WO (1) WO2002072528A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785273A1 (en) 1990-11-26 1997-07-23 Genetics Institute, Inc. Paired basic amino acid converting enzyme and DNA sequence encoding it
CA2452541A1 (en) * 2001-07-20 2003-01-30 Eli Lilly And Company (pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators
GB0308335D0 (en) 2003-04-10 2003-05-14 Novartis Ag Organic compounds
US6887896B1 (en) * 2003-10-29 2005-05-03 Allergan, Inc. 7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US20090232879A1 (en) 2005-05-26 2009-09-17 Metabasis Therapeutics, Inc. Thyromimetics for the Treatment of Fatty Liver Diseases
JP5149388B2 (ja) 2007-09-12 2013-02-20 ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 黄斑変性症を処置するための組成物及び方法
JP6723752B2 (ja) * 2015-02-10 2020-07-15 公益財団法人相模中央化学研究所 二次電池用電解液
WO2018094265A2 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
AU2018280118B2 (en) 2017-06-05 2021-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
EA202091979A1 (ru) 2018-03-22 2021-06-22 Вайкинг Терапьютикс, Инк. Кристаллические формы и способы получения кристаллических форм соединения
EP4775207A2 (en) 2018-12-05 2026-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
EP4161925A4 (en) 2020-06-09 2024-09-04 Viking Therapeutics, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5977125A (en) * 1994-10-31 1999-11-02 Eisai Co., Ltd. Mono-or polyenic carboxylic acid derivatives
EP0788353A1 (en) * 1995-09-18 1997-08-13 Ligand Pharmaceuticals, Inc. Ppar gamma antagonists for treating obesity
AU726450B2 (en) * 1995-10-06 2000-11-09 Ligand Pharmaceuticals Incorporated Dimer-selective RXR modulators and methods for their use
WO2000026172A1 (en) * 1998-11-03 2000-05-11 Ligand Pharmaceuticals Incorporated Trienoic retinoid compounds as retinoic acid receptor antagonists
CN1337931A (zh) * 1999-03-08 2002-02-27 巴斯利尔药物股份公司 类维生素a拮抗剂及其用途
US6593493B1 (en) * 1999-09-14 2003-07-15 Ligand Pharmaceuticals, Inc. RXR modulators with improved pharmacologic profile
CA2452541A1 (en) * 2001-07-20 2003-01-30 Eli Lilly And Company (pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators

Similar Documents

Publication Publication Date Title
Dai et al. Pd-catalysed decarboxylative Suzuki reactions and orthogonal Cu-based O-arylation of aromatic carboxylic acids
JPH052666B2 (cg-RX-API-DMAC10.html)
AU2010307094A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
CN104936591A (zh) 促红细胞生成素表达增强剂
JP2014527083A5 (cg-RX-API-DMAC10.html)
US3649679A (en) Substituted phenylalkanoic acid derivatives ii
JP2005511516A5 (cg-RX-API-DMAC10.html)
AU2002255732B2 (en) Fluorinated trienes and their use as RXR modulators
AU2002255732A1 (en) Fluorinated trienes and their use as RXR modulators
GB1499323A (en) 6-substituted chromones and chromanones
JP2005514327A5 (cg-RX-API-DMAC10.html)
JPS609711B2 (ja) 9−デオキシ−9−メチレンpgf類似体類
US4211727A (en) Reduction of carboxylic acid halides to aldehydes
JP4635343B2 (ja) 光学活性な銅錯体ならびに光学活性なサリチリデンアミノアルコール化合物およびそれを用いる光学活性なシクロプロパンカルボン酸誘導体の製造方法
US2608506A (en) Arylsulfamyl benzoic acids
RU2005125635A (ru) Производные инденонкарбоновых кислот и их применение для лечения и предотвращения диабета и дислипидемии
JP2019532071A5 (cg-RX-API-DMAC10.html)
AU2002319583A1 (en) (Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid X receptor modulators
WO2003007950A1 (en) (pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators
Farmer et al. Synthesis and structure-activity relationships of potent retinoid X receptor ligands
GB2365426A (en) Bactericidal benzamide derivatives
FR2864083A1 (fr) Nouveaux derives d'acides phenyl-boroniques et leurs procedes de preparation.
CN112028800B (zh) 半胱氨酸衍生物及其合成方法
Gilman et al. Use of the Halogen—Metal Interconversion Reaction for the Preparation of an Aromatic Iodo Compound
EP0879223B1 (fr) Derives polycycliques aromatiques de type retinoide, leur procede de preparation et leur utilisation pour la fabrication de compositions pharmaceutiques et cosmetiques